Skip to main content
Signal8

VOLITIONRX LTD (VNRX)

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Sector: In Vitro & In Vivo Diagnostic Substances

Industry: Medical - Devices

VolitionRX Ltd logo

VolitionRX Ltd

NYSE:VNRXHealthcare
-5.56%$0.1887
CLOSED
AH$0.1801-4.56%vs close
Mkt Cap$6.81M
EV-
Float35.56M
O/S36.08M
VOL3.08M sh
$ Vol$597K
RVOL0.81×
Inst Own7.5%
SI3.9%
Net Cash/Sh-
Dilution
VolitionRX Ltd logoNYSE:VNRXClosed$0.1887-5.56%
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›